関連する実験動画

Updated: Aug 15, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

レイ症候群とアスピリンの関連:少し強い

W Check

    JAMA
    |March 19, 1982
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
    09:33

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

    Published on: September 13, 2016

    Iris Fixation via External Pentagram Suturing
    05:22

    Iris Fixation via External Pentagram Suturing

    Published on: May 5, 2022

    関連する実験動画

    Last Updated: Aug 15, 2026

    Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
    07:49

    Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

    Published on: September 17, 2014

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
    09:33

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

    Published on: September 13, 2016

    Iris Fixation via External Pentagram Suturing
    05:22

    Iris Fixation via External Pentagram Suturing

    Published on: May 5, 2022

    関連する概念動画

    Allergic Reactions02:06

    Allergic Reactions

    Overview
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ